Integrated biomarkers in cardiomyopathies: cardiovascular magnetic resonance imaging combined with molecular and immunologic markers--a stepwise approach for diagnosis and treatment.
In an integrated approach, the authors examine the most efficient combination of noninvasive and invasive biochemical, immunologic, functional, molecular, imaging and biopsy-derived biomarkers for their applicability in the diagnosis of cardiomyopathies in general and dilated cardiomyopathy (DCM) in particular. A careful selection out of the cascade of available biomarkers will allow, in individual patients, to diagnose certain conditions of cardiomyopathies without endomyocardial biopsy, e.g., borreliosis, rickettsiosis, HIV cardiomyopathy. Viral persistence in DCM associated with inflammation will need both noninvasive (echocardiography, cardiovascular magnetic resonance) and invasive biomarkers (polymerase chain reaction for viral persistence or their exclusion in case of autoreactive myocarditis and quantitative immunohistology, both from endomyocardial biopsy).
Schulz-Menger
Jeanette
J
Cardiology, Franz Volhard Clinic, Charité Campus Buch, Helios Klinikum Berlin, University Medicine, Berlin, and Department of Internal Medicine-Cardiology, University Hospital Giessen, Marburg, Germany. jeanette.schulz-menger@charite.de
Maisch
Bernhard
B
Abdel-Aty
Hassan
H
Pankuweit
Sabine
S
D015415:Biomarkers / Q000097:blood*; D009202:Cardiomyopathies / Q000097:blood* / Q000175:diagnosis; D006801:Humans; D007155:Immunologic Factors / Q000097:blood*; D008279:Magnetic Resonance Imaging / Q000379:methods*; D015336:Molecular Probe Techniques
D015415:Biomarkers; D007155:Immunologic Factors